Paper42465026
Unc-51 like kinase 3 induces reticulophagy by mediating the GLI1/CAMK2B signaling pathway to promote the malignant progression of prostate cancer.
Wang QQ and 4 others. Am J Cancer Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Unc-51 like kinase 3 induces reticulophagy by mediating the GLI1/CAMK2B signaling pathway to promote the malignant progression of prostate cancer. Papers, record 42465026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42465026
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unc-51 like kinase 3 induces reticulophagy by mediating the GLI1/CAMK2B signaling pathway to promote the malignant progression of prostate cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36797248 | The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome. | Nat Commun | 2023 | https://conductscience.org/library/papers/36797248 | PubMed |
| 2 | 35327508 | ER-phagy in the Occurrence and Development of Cancer. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327508 | PubMed |
| 3 | 36277220 | Sec61 complex/translocon: The role of an atypical ER Ca2+-leak channel in health and disease. | Front Physiol | 2022 | https://conductscience.org/library/papers/36277220 | PubMed |
| 4 | 28877478 | The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. | Cell Rep | 2017 | https://conductscience.org/library/papers/28877478 | PubMed |
| 5 | 36080493 | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. | Molecules | 2022 | https://conductscience.org/library/papers/36080493 | PubMed |
| 6 | 15483020 | Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15483020 | PubMed |
| 7 | 23485231 | Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. | Eur J Cancer | 2013 | https://conductscience.org/library/papers/23485231 | PubMed |
| 8 | 24399786 | Cancer statistics, 2014. | CA Cancer J Clin | 2014 | https://conductscience.org/library/papers/24399786 | PubMed |
| 9 | 32904557 | The Significance of Circular RNA DDX17 in Prostate Cancer. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32904557 | PubMed |
| 10 | 30633901 | Biological Functions of Autophagy Genes: A Disease Perspective. | Cell | 2019 | https://conductscience.org/library/papers/30633901 | PubMed |
| 11 | 32898766 | A zinc finger family protein, ZNF263, promotes hepatocellular carcinoma resistance to apoptosis via activation of ER stress-dependent autophagy. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32898766 | PubMed |
| 12 | 33557050 | Treating Prostate Cancer by Antibody-Drug Conjugates. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33557050 | PubMed |
| 13 | 31181727 | ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31181727 | PubMed |
| 14 | 30540126 | Autophagy and intermittent fasting: the connection for cancer therapy? | Clinics (Sao Paulo) | 2018 | https://conductscience.org/library/papers/30540126 | PubMed |
| 15 | 31357527 | PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31357527 | PubMed |
| 16 | 29356327 | Functions of autophagy in the tumor microenvironment and cancer metastasis. | FEBS J | 2018 | https://conductscience.org/library/papers/29356327 | PubMed |
| 17 | 41234868 | Bioinformatics analysis identifies ULK3 as a novel prognostic and immune-related biomarker in esophageal cancer. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41234868 | PubMed |
| 18 | 19279323 | Autophagy mediates the mitotic senescence transition. | Genes Dev | 2009 | https://conductscience.org/library/papers/19279323 | PubMed |
| 19 | 36979155 | FGFR2c Upregulation Contributes to Cancer-Associated Fibroblast Program Activation and to Enhanced Autophagy in Actinic Keratosis-Derived Dermal Fibroblasts: A Possible Role in Precancerous Cell/Stromal Cell Crosstalk. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36979155 | PubMed |
| 20 | 31930741 | FAM134B oligomerization drives endoplasmic reticulum membrane scission for ER-phagy. | EMBO J | 2020 | https://conductscience.org/library/papers/31930741 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAMK2B | 816 | PubTator's text mining | https://conductscience.org/library/genes/816 | NCBI Gene |
| GLI1 | 2735 | PubTator's text mining | https://conductscience.org/library/genes/2735 | NCBI Gene |
| ULK3 | 25989 | PubTator's text mining | https://conductscience.org/library/genes/25989 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42465026
GET https://conductscience.org/api/papers/v1/42465026/references?page=2